U.S. Markets open in 8 hrs 13 mins

Imprimis Pharmaceuticals, Inc. (IMMY)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.64-0.01 (-0.38%)
At close: 4:00PM EDT
People also watch
IPWREVOKDPRXOCRXINNL
Full screen
Previous Close2.65
Open2.70
Bid0.00 x
Ask0.00 x
Day's Range2.55 - 2.71
52 Week Range1.65 - 4.69
Volume204,473
Avg. Volume168,276
Market Cap52.97M
Beta1.38
PE Ratio (TTM)-2.00
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cubelast month

    ETFs with exposure to Imprimis Pharmaceuticals, Inc. : June 19, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Imprimis Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IMMY-US. Comparing the performance and risk of Imprimis Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Imprimis Pharmaceuticals, Inc. : June 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Imprimis Pharmaceuticals, Inc. Here are 5 ETFs with the largest exposure to IMMY-US. Comparing the performance and risk of Imprimis Pharmaceuticals, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Imprimis Pharmaceuticals, Inc. :IMMY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017
    Capital Cube2 months ago

    Imprimis Pharmaceuticals, Inc. :IMMY-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017

    Categories: Yahoo FinanceGet free summary analysis Imprimis Pharmaceuticals, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Imprimis Pharmaceuticals, Inc. – Akorn, Inc., Antares Pharma, Inc., Retractable Technologies, Inc., Delcath Systems, Inc., ICU Medical, Inc. and Tandem Diabetes Care, Inc. (AKRX-US, ATRS-US, RVP-US, DCTH-US, ICUI-US ... Read more (Read more...)